Lone Pine Capital
SuperinvestorLone Pine Capital LLC
- SEC CIK
- 0001061165
- Manager
- Stephen Mandel
- Style
- Growth, Hedge fund
- Latest filing
- Aug 14, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by Lone Pine Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −1,529,618−100.0% | Sold out | Holders |
| Q2 2023 | 1,529,618 | $185.8M | 1.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,529,618 | $234.9M | 2.2% | +177,100+13.1% | Added | Holders |
| Q4 2022 | 1,352,518 | $242.9M | 2.3% | +1,352,518 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −3,316,199−100.0% | Sold out | Holders |
| Q3 2021 | 3,316,199 | $1.28B | 4.3% | −674,698−16.9% | Reduced | Holders |
| Q2 2021 | 3,990,897 | $937.8M | 3.0% | +3,990,897 | New | Holders |